中国急性冠脉综合征患者院内管理与结局的性别差异
女性年龄更大、合并症更多,调整后女性接受循证急性治疗和二级预防策略的比例低于男性,院内死亡率高于男性,但调整临床特征和急性治疗后性别差异不再显著。
要点
- 中国ACS女性患者年龄更大、合并症更多,接受循证急性治疗和二级预防的比例低于男性。
- 女性院内死亡率高于男性,但调整临床特征和急性治疗后性别差异不再显著。
- 针对女性的质量改进项目可能有助于缩小ACS诊疗和结局的性别差异。
核心结论
- 中国ACS住院女性接受急性治疗和二级预防策略的频率低于男性。
- 观察到的院内死亡率性别差异主要归因于女性更差的临床特征和更少的循证急性治疗。
- 可能需要专门针对性的质量改进项目来缩小ACS诊疗质量和结局的性别差异。
研究设计与样本
- CCC-ACS项目是由美国心脏协会和中华医学会心血管病学分会持续开展的全国性注册研究。
主要发现
- 女性ACS患者年龄大于男性(69.0岁 vs 61.1岁,P<0.001),且合并症更多。
- 多变量调整后,符合条件的女性较男性更少接受循证急性治疗,包括早期双联抗血小板治疗、住院期间肝素和ST段抬高型心肌梗死的再灌注治疗。
- 符合条件的女性较男性更少接受二级预防策略,包括出院时双联抗血小板治疗、血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂、他汀类药物,以及住院期间戒烟和心脏康复咨询。
- 女性院内死亡率高于男性(2.60% vs 1.50%,P<0.001)。
- 调整临床特征和急性治疗后,ST段抬高型心肌梗死患者(调整比值比1.18;95%CI 1.00至1.41;P=0.057)和非ST段抬高型ACS患者(调整比值比0.84;95%CI 0.66至1.06;P=0.147)中院内死亡率的性别差异不再观察到。
临床怎么用
- 临床应关注女性ACS患者循证急性治疗和二级预防策略的充分应用,以缩小诊疗差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary heart disease is a leading cause of mortality among women. Systematic evaluation of the quality of care and outcomes in women hospitalized for acute coronary syndrome (ACS), an acute manifestation of coronary heart disease, remains lacking in China. METHODS: The CCC-ACS project (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) is an ongoing nationwide registry of the American Heart Association and the Chinese Society of Cardiology. Using data from the CCC-ACS project, we evaluated sex differences in acute management, medical therapies for secondary prevention, and in-hospital mortality in 82 196 patients admitted for ACS at 192 hospitals in China from 2014 to 2018. RESULTS: Women with ACS were older than men (69.0 versus 61.1 years, P<0.001) and had more comorbidities. After multivariable adjustment, eligible women were less likely to receive evidence-based acute treatments for ACS than men, including early dual antiplatelet therapy, heparins during hospitalization, and reperfusion therapy for ST-segment-elevation myocardial infarction. With respect to strategies for secondary prevention, eligible women were less likely to receive dual antiplatelet therapy, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, statins at discharge, and smoking cessation and cardiac rehabilitation counseling during hospitalization. In-hospital mortality rate was higher in women than in men (2.60% versus 1.50%, P<0.001). The sex difference in in-hospital mortality was no longer observed in patients with ST-segment-elevation myocardial infarction (adjusted odds ratio, 1.18; 95% CI, 1.00 to 1.41; P=0.057) and non-ST-segment elevation ACS (adjusted odds ratio, 0.84; 95% CI, 0.66 to 1.06; P=0.147) after adjustment for clinical characteristics and acute treatments. CONCLUSIONS: Women hospitalized for ACS in China received acute treatments and strategies for secondary prevention less frequently than men. The observed sex differences in in-hospital mortality were mainly attributable to worse clinical profiles and fewer evidence-based acute treatments provided to women with ACS. Specially targeted quality improvement programs may be warranted to narrow sex-related disparities in quality of care and outcomes in patients with ACS. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02306616.
引用
- Hao Y, Liu J, Liu J, et al. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome. Circulation. 2019. PMID: 30667281. doi:10.1161/CIRCULATIONAHA.118.037655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。